Results for SARS-CoV-2 Spike Protein

Adverse effects of COVID-19 vaccines and measures to prevent them.

Article Published Date : Jun 04, 2022
Study Type : Commentary
Additional Links
Diseases : Vaccination: Coronavirus
Additional Keywords : Antibody-Dependent Enhancement, SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)
Adverse Pharmacological Actions : Immunosuppressive : CK(289) : AC(55)

Be aware of SARS-CoV-2 spike protein: There is more than meets the eye.

Article Published Date : Jan 07, 2021
Study Type : Commentary
Additional Links
Substances : Luteolin : CK(709) : AC(391)
Diseases : Coronavirus Infection : CK(3297) : AC(986), Vaccination: Coronavirus
Pharmacological Actions : Antioxidants : CK(33994) : AC(14222)
Additional Keywords : SARS-CoV-2 Spike Protein

Biodistribution of mRNA COVID-19 vaccines in human breast milk.

Article Published Date : Sep 18, 2023
Study Type : Human Study
Additional Links
Diseases : Vaccination: Coronavirus, Vaccine-induced Toxicity : CK(3602) : AC(665)
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1.

Article Published Date : Nov 02, 2022
Study Type : Animal Study
Additional Links
Substances : Lactoferrin : CK(813) : AC(308)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Cannabinoids block cellular entry of SARS-CoV-2 and the emerging variants.

Article Published Date : Jan 27, 2022
Study Type : In Vitro Study
Additional Links
Substances : Cannabinoids : CK(2714) : AC(922)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Cardiac side effects of RNA-based SARS-CoV-2 vaccines.

Article Published Date : Oct 11, 2023
Study Type : In Vitro Study
Additional Links
Diseases : Cardiomyopathy : CK(358) : AC(160), Vaccine-induced Toxicity : CK(3602) : AC(665)
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)
Adverse Pharmacological Actions : Cardiotoxic : CK(1168) : AC(209)

CBD is a powerful inhibitor of SARS-CoV-2 spike protein enterotoxicity in vitro.

Article Published Date : Oct 11, 2021
Study Type : In Vitro Study
Additional Links
Substances : Cannabidiol : CK(3371) : AC(1007)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Anti-Inflammatory Agents : CK(38446) : AC(15385), Interleukin-18 upregulation : CK(15) : AC(10), Interleukin-1 beta downregulation : CK(5878) : AC(2865), Interleukin-6 Downregulation : CK(9170) : AC(3542), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11372) : AC(4686)
Additional Keywords : SARS-CoV-2 Spike Protein

Certain natural compounds could help minimize the neuro- aspects of long covid.

Article Published Date : Feb 21, 2023
Study Type : Review
Additional Links
Substances : Eriodictyol : CK(83) : AC(55), Oleuropein : CK(322) : AC(202), Sulforaphane : CK(1342) : AC(629)
Diseases : Brain: Microglial Activation : CK(192) : AC(114), Brain Inflammation : CK(1747) : AC(907), Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Anti-Inflammatory Agents : CK(38446) : AC(15385), Antiviral Agents : CK(3077) : AC(1693), Neuroprotective Agents : CK(19672) : AC(7790)
Additional Keywords : Long Covid, SARS-CoV-2 Spike Protein

Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome?

Article Published Date : Jan 12, 2022
Study Type : Review
Additional Links
Diseases : Coronavirus Infection : CK(3297) : AC(986), Vaccination: Coronavirus
Additional Keywords : Long Covid, SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers.

Article Published Date : Dec 31, 2021
Study Type : Human: Case Report
Additional Links
Diseases : Inflammation : CK(15586) : AC(5304), Vaccine-induced Toxicity : CK(3602) : AC(665)
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

Dieckol and Its derivatives as potential inhibitors of SARS-CoV-2 spike protein.

Article Published Date : Apr 24, 2021
Study Type : In Vitro Study
Additional Links
Substances : Phlorotannins : CK(148) : AC(98)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Eugenol inhibits the interaction between SARS-CoV-2 spike S1 and ACE2 to induce therapeutic responses.

Article Published Date : Oct 21, 2021
Study Type : In Vitro Study
Additional Links
Substances : Eugenol : CK(217) : AC(132)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Anti-Inflammatory Agents : CK(38446) : AC(15385), Antiviral Agents : CK(3077) : AC(1693), Interleukin-1 beta downregulation : CK(5878) : AC(2865), Interleukin-6 Downregulation : CK(9170) : AC(3542), NF-kappaB Inhibitor : CK(5826) : AC(3390), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11372) : AC(4686)
Additional Keywords : SARS-CoV-2 Spike Protein

First case of postmortem study in a patient vaccinated against SARS-CoV-2.

Article Published Date : May 31, 2021
Study Type : Human: Case Report
Additional Links
Diseases : Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

Full-length spike protein unbound by antibodies was detected in the plasma of individuals with postvaccine myocarditis.

Article Published Date : Jan 03, 2023
Study Type : Human Study
Additional Links
Diseases : Myocarditis : CK(281) : AC(43), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)
Adverse Pharmacological Actions : Cardiotoxic : CK(1168) : AC(209)

Functionalized fullerene for inhibition of SARS-CoV-2 variants.

Article Published Date : Mar 31, 2023
Study Type : In Vitro Study
Additional Links
Substances : Carbon 60 : CK(79) : AC(48)
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Ginkgolic acids inhibit SARS-CoV-2 and its variants.

Article Published Date : Jan 30, 2023
Study Type : In Vitro Study
Additional Links
Substances : Ginkgo biloba : CK(2025) : AC(644)
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein.

Article Published Date : May 16, 2023
Study Type : Review
Additional Links
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds.

Article Published Date : Sep 21, 2021
Study Type : In Vitro Study
Additional Links
Substances : Curcumin : CK(7056) : AC(3241), Kaempferol : CK(344) : AC(228)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

In vitro effect of Taraxacum officinale leaf aqueous extract on the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614 and four mutants.

Article Published Date : Oct 16, 2021
Study Type : In Vitro Study
Additional Links
Substances : Dandelion : CK(370) : AC(200)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike protein.

Article Published Date : Jul 22, 2024
Study Type : In Vitro Study
Additional Links
Diseases : Cystic Fibrosis : CK(787) : AC(123), Inflammation : CK(15586) : AC(5304), Vaccine-induced Toxicity : CK(3602) : AC(665)
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)
Adverse Pharmacological Actions : Inflammatory : CK(541) : AC(169)

Inhibition of multiple SARS-CoV-2 variants entry by Lycium barbarum L. polysaccharides.

Article Published Date : Feb 29, 2024
Study Type : In Vitro Study
Additional Links
Substances : Goji : CK(425) : AC(185)
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : Polysaccharides : CK(1322) : AC(746), SARS-CoV-2 Spike Protein

Interactions of spike-RBD of SARS-CoV-2 and platelet factor 4: new insights in the etiopathogenesis of thrombosis.

Article Published Date : Aug 08, 2021
Study Type : Human In Vitro
Additional Links
Diseases : Thrombosis : CK(444) : AC(121), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

Intramyocardial inflammation after COVID-19 vaccination: an endomyocardial biopsy-proven case series.

Article Published Date : Jun 21, 2022
Study Type : Human Study
Additional Links
Diseases : Inflammation : CK(15586) : AC(5304), Vaccine-induced Toxicity : CK(3602) : AC(665)
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)
Adverse Pharmacological Actions : Cardiotoxic : CK(1168) : AC(209), Inflammatory : CK(541) : AC(169)

Lactoferrin for COVID-19 prevention, treatment, and recovery.

Article Published Date : Dec 31, 2021
Study Type : Review
Additional Links
Substances : Lactoferrin : CK(813) : AC(308)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693), Prophylactic Agents : CK(1561) : AC(316)
Additional Keywords : SARS-CoV-2 Spike Protein

Lonicerae japonicae attenuates neutrophilic inflammation by inhibiting oxidative stress.

Article Published Date : Sep 08, 2022
Study Type : In Vitro Study
Additional Links
Substances : Honeysuckle : CK(250) : AC(145)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Anti-Inflammatory Agents : CK(38446) : AC(15385), Antioxidants : CK(33994) : AC(14222)
Additional Keywords : SARS-CoV-2 Spike Protein

Molecular mimicry between SARS-CoV-2 and the female reproductive system.

Article Published Date : Aug 17, 2021
Study Type : In Vitro Study
Additional Links
Diseases : Coronavirus Infection : CK(3297) : AC(986), Infertility: Female : CK(749) : AC(184), Vaccination: Coronavirus
Additional Keywords : Molecular Mimicry : CK(109) : AC(32), SARS-CoV-2 Spike Protein

mulberrofuran G might be a promising therapeutic candidate for preventing SARS-CoV-2.

Article Published Date : Oct 06, 2022
Study Type : In Vitro Study
Additional Links
Substances : Mulberry : CK(546) : AC(274)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Mulberry component kuwanon C exerts potent therapeutic efficacy in vitro against COVID-19.

Article Published Date : Oct 18, 2022
Study Type : In Vitro Study
Additional Links
Substances : White Mulberry : CK(156) : AC(66)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Nattokinase exhibits potential for the inhibition of SARS-CoV-2 infection via S protein degradation.

Article Published Date : Aug 23, 2022
Study Type : In Vitro Study
Additional Links
Substances : Nattokinase : CK(107) : AC(20)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin.

Article Published Date : Aug 31, 2023
Study Type : In Vitro Study
Additional Links
Substances : Fucoidan : CK(866) : AC(451)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Near-infrared light exposure triggers ROS to downregulate inflammatory cytokines induced by SARS-CoV-2 spike protein in human cell culture.

Article Published Date : Oct 01, 2023
Study Type : In Vitro Study
Additional Links
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297)
Therapeutic Actions : Photobiomodulation : CK(9804) : AC(2008)
Pharmacological Actions : Anti-Inflammatory Agents : CK(38446) : AC(15385), Antioxidants : CK(33994) : AC(14222)
Additional Keywords : SARS-CoV-2 Spike Protein

Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker.

Article Published Date : May 31, 2021
Study Type : In Vitro Study
Additional Links
Substances : Flavonoids : CK(4695) : AC(2173)
Diseases : Coronavirus Infection : CK(3297) : AC(986), Severe Acute Respiratory Syndrome : CK(116) : AC(28)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Postbiotic preparation of Lacticaseibacillus rhamnosus GG against diarrhea and oxidative stress induced by spike protein of SARS-CoV-2.

Article Published Date : Oct 18, 2023
Study Type : In Vitro Study
Additional Links
Substances : Lactobacillus rhamnosus GG : CK(660) : AC(147)
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297), Diarrhea : CK(1073) : AC(188)
Pharmacological Actions : Antioxidants : CK(33994) : AC(14222), Gastrointestinal Agents : CK(7505) : AC(2225)
Additional Keywords : SARS-CoV-2 Spike Protein

Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.

Article Published Date : Apr 12, 2021
Study Type : In Vitro Study
Additional Links
Substances : Flavonoids : CK(4695) : AC(2173)
Diseases : Coronavirus Infection : CK(3297) : AC(986)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins.

Article Published Date : Jun 27, 2022
Study Type : In Vitro Study
Additional Links
Diseases : Autoimmune Diseases : CK(11878) : AC(2640), Vaccine-induced Toxicity : CK(3602) : AC(665)
Additional Keywords : Molecular Mimicry : CK(109) : AC(32), SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

Prenol of fruit binds to SARS-CoV-2 spike S1 to inhibit viral entry.

Article Published Date : May 04, 2023
Study Type : Animal Study
Additional Links
Substances : Fruit: All : CK(9379) : AC(2226)
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

Rosemary may reduce the risk of SARS-CoV-2 infection and the development of COVID-19.

Article Published Date : Dec 05, 2023
Study Type : In Vitro Study
Additional Links
Substances : Rosemary : CK(555) : AC(211)
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297)
Pharmacological Actions : Antiviral Agents : CK(3077) : AC(1693)
Additional Keywords : SARS-CoV-2 Spike Protein

SARS-2-cov spike protein alone without the rest of the viral components is sufficient to elicit cell signaling in human pulmonary arterial endothelial cells.

Article Published Date : Aug 21, 2021
Study Type : In Vitro Study
Additional Links
Diseases : Coronavirus Infection : CK(3297) : AC(986), Endothelial Dysfunction : CK(2715) : AC(574), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.

Article Published Date : Jan 03, 2020
Study Type : Human Study
Additional Links
Diseases : Coronavirus Infection : CK(3297) : AC(986), Inflammation : CK(15586) : AC(5304), Thrombosis : CK(444) : AC(121), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

SARS-CoV-2 spike aggravates lupus nephritis and lung fibrosis in systemic lupus erythematosus.

Article Published Date : Sep 29, 2024
Study Type : Animal Study
Additional Links
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297), Fibrosis : CK(373) : AC(179), Lupus Nephritis : CK(128) : AC(33), Systemic Lupus Erythematosus : CK(797) : AC(137)
Additional Keywords : Increased Risk : CK(8703) : AC(1109), SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

SARS-CoV-2 spike impairs DNA damage repair and inhibits V(D)J recombination in vitro.

Article Published Date : Jan 12, 2021
Study Type : In Vitro Study
Additional Links
Diseases : Vaccination: Coronavirus
Additional Keywords : BRCA Gene : CK(40) : AC(9), SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9.

Article Published Date : Dec 31, 2023
Study Type : Animal Study
Additional Links
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297)
Additional Keywords : SARS-CoV-2 Spike Protein
Adverse Pharmacological Actions : Gastrotoxic : CK(192) : AC(69)

SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS.

Article Published Date : Aug 26, 2021
Study Type : In Vitro Study
Additional Links
Diseases : Inflammation : CK(15586) : AC(5304), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

SARS-CoV-2 spike protein accelerates systemic sclerosis by increasing inflammatory cytokines, Th17 cells, and fibrosis.

Article Published Date : Dec 20, 2023
Study Type : In Vitro Study
Additional Links
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297), Scleroderma: Systemic : CK(51) : AC(10)
Additional Keywords : SARS-CoV-2 Spike Protein
Adverse Pharmacological Actions : Inflammatory : CK(541) : AC(169)

SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate.

Article Published Date : Oct 28, 2021
Study Type : Animal Study
Additional Links
Diseases : Thrombosis : CK(444) : AC(121), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein

SARS-CoV-2 spike protein exacerbates inflammation and hypercoagulation.

Article Published Date : Oct 01, 2024
Study Type : Animal Study
Additional Links
Diseases : Inflammation : CK(15586) : AC(5304), Stroke: Ischemic : CK(1007) : AC(274)
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE2.

Article Published Date : Dec 03, 2020
Study Type : Animal Study, In Vitro Study
Additional Links
Diseases : Endothelial Damage : CK(255) : AC(67), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein

SARS-CoV-2 spike protein induces hemagglutination: implications for COVID-19 morbidities and therapeutics and for vaccine adverse effects.

Article Published Date : Dec 06, 2022
Study Type : In Vitro Study
Additional Links
Diseases : Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

SARS-CoV-2 spike protein induces oxidative stress and senescence in mouse and human lung.

Article Published Date : Dec 31, 2023
Study Type : Animal Study, Human In Vitro
Additional Links
Diseases : Coronavirus Disease (Covid-19) : CK(1185) : AC(297), Lung Inflammation : CK(235) : AC(96), Oxidative Stress : CK(14378) : AC(5533), Vaccine-induced Toxicity : CK(3602) : AC(665)
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesion in endothelial cells.

Article Published Date : Jan 09, 2021
Study Type : In Vitro Study
Additional Links
Diseases : Coronavirus Infection : CK(3297) : AC(986), Endothelial Damage : CK(255) : AC(67), Endothelial Dysfunction : CK(2715) : AC(574), Vaccination: Coronavirus
Additional Keywords : SARS-CoV-2 Spike Protein
Anti Therapeutic Actions : Vaccination: COVID-19 : CK(960) : AC(212)

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.